Intranasal flu vaccine
Executive Summary
Vanderbilt University to conduct a five-year efficacy study of a live attenuated vaccine administered intransally. The vaccine, produced by Flow Labs under a contract from NIH, will be compared to both a conventional injection of killed infuenza virus and placebo. Study will involve 3,000 patients.